Dan Ding

Director, Regulatory Affairs @ Insilico Medicine

About

Over 14 years of pharmaceutical industrial experience, of which 13 years in global regulatory affairs (INDs, NDA & post-marketing variation) and 1year in medicinal chemistry and PM.

Country

China

City

Shanghai

Industry

Pharmaceuticals

Skill

Microsoft Office, Leadership, Microsoft Excel, Editing, PowerPoint, Microsoft Word, Marketing, Process Improvement, Marketing Communications, Social Media, Pharmaceutical Industry

Experience

Director, Regulatory Affairs

Insilico Medicine

2022-11 - Present · 3 yrs 11 mos

中国上海市

Associate Director, Global Regulatory Affairs

ImageneBio

2021-5 - 2022-11 · 1 yr 7 mos

Led global regulatory affairs (Including China, US, Taiwan, South Korea, AUS) for multiple mid- to late-stage programs.

Senior Manager, Regulatory Affairs

Hua Medicine

2017-5 - 2021-5 · 4 yrs 1 mo

中国上海市

Led end-to-end regulatory activities for several programs. A key achievement was managing the complete regulatory lifecycle of a product from Phase II to NDA approval, which ultimately achieved regulatory approval and market authorization.

Global Regulatory Affairs

Pfizer

2013-9 - 2017-5 · 3 yrs 9 mos

Shanghai Suburb, China

Contributed to the global regulatory activities for a diverse portfolio that included multiple well-known branded therapeutics. Responsibilities encompassed all stages from early clinical trial applications (IND) to marketing authorization (NDA) and post-approval lifecycle management.